Clinical Evaluation of a Bacterially-Derived Healon5 Ophthalmic Viscosurgical Device

This randomized trial demonstrated noninferiority of the novel bacterially-derived Healon5 PRO to animal-derived Healon5 ophthalmic viscosurgical devices regarding effectiveness and safety during cataract surgery. Both OVDs had clinically similar performance.

Source: Journal of Cataract and Refractive Surgery - August 8, 2019 Category: Opthalmology Authors: Daniel H. Chang, William C. Christie, James C. Loden, Pamela J. Smith, Beth E. Jackson Source Type: research